AestheticsFeatured Articles

What are the Skincare Benefits of Niacinamide?

By September 28, 2020No Comments

Featured Article

Featured Article

A 2016 study from Journal of Drugs in Dermatology suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read more

A 2016 study from Journal of Drugs in Dermatology (“Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol“), which was recently cited in an article on Prevention.com, suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection. 

Patricia Farris MD, Joshua Zeichner MD, and Diane Berson MD

 

Consumers are increasingly interested in over-the-counter skin care products that can improve the appearance of photodamaged and aging skin. This 10-week, open-label, single- center study enrolled 25 subjects with mild to moderate hyperpigmentation and other clinical stigmata of cutaneous aging including fine lines, sallowness, lack of clarity, and wrinkling. Their mean age was 53.4±7.7 years. The test product contained retinol 0.5% in combination with niacinamide 4.4%, resveratrol 1%, and hexylresorcinol 1.1% in a moisturizing base. Subjects were provided a skin care regimen including a cleanser, hydrating serum, moisturizer, and an SPF 30 sunscreen for daily use. The test product was applied only at night.

The use of this skin brightening/anti-aging cosmeceutical was found to provide statistically significant improvements in all efficacy endpoints by study end. Fine lines, radiance, and smoothness were significantly improved as early as week 2 (P<.001). By week 4, hyperpigmentation, overall skin clarity, evenness of skin tone, and wrinkles showed statistically significant improvement compared to baseline. Mild retinoid dermatitis including flaking and redness occurred early in the study as reflected by tolerability scores. By week 10, subjects reported no stinging, itching, dryness, or tingling.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article about Practical Algorithm for Acne Treatment Integrating Skincare and Energy Based Devices

Practical Algorithm for Acne Treatment Integrating Skincare and Energy Based Devices

| Acne, Featured Articles, Latest News, Skincare | No Comments
A practical, consensus driven algorithm to help clinicians combine topical care and device therapies We wanted to share this February 2026 article that has been gaining a lot of attention.…
Journal of Drugs in Dermatology JDD Article about Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

| Featured Articles, Latest News, Medical Derm | No Comments
A large real world TriNetX analysis reports an association between antiviral treatment for oral or mucocutaneous HSV and lower rates of Alzheimer disease and dementia If you’ve missed this must-read…
Journal of Drugs in Dermatology JDD Article about From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

| Featured Articles, Latest News, Medical Derm | No Comments
Have you read this JDD review on Th17 pathway defects and chronic mucocutaneous candidiasis? We pulled this one from the JDD vault - a must read article that dates back…

Leave a Reply